Supreme: FY26 revenue and adjusted EBITDA expected to be significantly ahead of expectations
In a crisis riddled world marked by wars from Ukraine to the Middle East – one would expect consumer demand to wobble. Yet across the UK’s FMCG, drinks, wellness and vaping markets, consumption remains remarkably resilient. Why? Because these are everyday, affordable products -small-ticket essentials and “feel-good” purchases that people continue to enjoy.
Enter Supreme , an entrepreneurial group that’s quietly building one of the UK’s most diversified and agile FMCG platforms. By assembling a stable of high-performing brands - ranging from Typhoo Tea and Clearly Drinks Ltd to SCI-MX Nutrition and SlimFast, alongside its heritage vaping arm. Crucially, that pivot towards Drinks & Wellness is not just defensive - it’s tapping into powerful structural growth trends around health, hydration and nutrition.
And today’s FY26 trading update shows that strategy is working.
Supreme PLC delivered a standout performance for the year to March, with revenues jumping 15% to £265m and EBITDA hitting £40.6m, comfortably ahead of expectations . This is no small feat given the well-publicised disruption from the UK’s disposable vape ban. Yet impressively, vaping sales still grew more than 10% year-on-year, underlining management’s successful transition to alternative formats.
Elsewhere, the £20.1m acquisition of SlimFast UK in Oct’25 has already made an “excellent” contribution, while ongoing investment in manufacturing, including a new 40,000 sq.ft wellness facility, positions the division for sustained expansion. Combined with a vertically integrated model and access to 55,000 retail outlets, Supreme has built a powerful engine for cross-selling and margin enhancement.
CEO Sandy Chadha commenting: the group has delivered “record financial results… significantly ahead of expectations,” supported by acquisitions, new products and strong underlying trading.
Looking forward,Shore Capital has upgraded FY26 expectations to £265m revenue and £40.6m EBITDA, with FY27 revenues climbing further to £295m. Moreover, the shares trade on attractive 7.2x FY26 PER and 4.0x EV/EBITDA multiples, alongside offering a 3.4% dividend yield with net cash (est £3.1m). FY27 multiples remain modest too at 7.6x PER and 4.0x EV/EBITDA, suggesting the market is yet to fully price in the group’s diversification and earnings power.
Sure there’s a new UK vaping tax being introduced from Oct’26 onwards. Yet equally Supreme PLC looks like a business leveraging its scale, channel strength, FMCG brands and product diversification to deliver growth in even the toughest of backdrops.
Disclosure: Supreme PLC is a Vox Markets client.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
